Incyte evp Heeson Lee sells $1.29 million in stock
Incyte Executive Vice President Heeson Lee sold 10,694 shares of the company's common stock on November 13, 2026, totaling around $1.29 million. The shares were sold at prices ranging from $120.3307 to $121.89, with the transactions taking place in multiple transactions. Following the sales, Lee still owns 26,884 shares, including issuable shares from previously granted restricted stock units.
Incyte's stock price currently sits at $114.63, down 5.25% over the past week, and is considered undervalued by analysts. Recent analysts' revisions include a downward shift in 9 of them for the upcoming earnings period. Incyte has seen upgrades from Oppenheimer and Mizuho, while Jefferies maintained a Hold rating. The company has also announced it will not pursue a planned Phase 3 clinical trial for its CDK2 inhibitor in ovarian cancer, prioritizing its clinical portfolio.
Rewritten by urgent.news; may contain errors — check the original.
Source: investing.com